Fabrication of drug loaded biodegradable polymer fibers
View Patent ↗The invention provides tissue engineering compositions and methods wherein three-dimensional matrices for growing cells are prepared for in vitro and in vivo use. The matrices comprise biodegradable polymer fibers capable of the controlled delivery of therapeutic agents. The spatial and temporal distribution of released therapeutic agents is controlled by use of defined nonhomogeneous patterns of therapeutic agents in the matrices.
1. A method of extruding a drug releasing fiber from chitosan comprising use of hydrochloric acid as a solvent and Tris base as coagulating bath.
2. The method of claim 1 , wherein the hydrochloric acid concentration is from about 0.25% to about 5%.
3. The method of claim 1 , wherein the tris base concentration is from about 2% to about 25%.
4. The method of claim 1 , comprising using a heterogeneous mixture comprising chitosans with different degrees of deacetylation.
5. The method of claim 1 , comprising creating a drug releasing fiber comprising segments of chitosan with different degrees of deacetylation.
6. The method of claim 1 , comprising creating a drug releasing fiber from chitosan and an extracellular matrix.
7. The method of claim 6 , wherein the chitosan concentration is from about 0.5 wt. % to about 10 wt. %.
8. The method of claim 6 , wherein said extracellular matrix comprises Matrigel.
9. The method of claim 6 , wherein the extracellular matrix concentration is from about 1 vol. % to about 20 vol. %.
10. The method of claim 1 , comprising coating said fiber with said extracellular matrix.
11. The method of claim 1 , wherein a portion of said chitosan is sulfated chitosan.
12. The method of claim 1 , wherein the sulfated chitosan concentration is from about 0.025 wt % to about 2 wt %.
13. A method of creating a drug releasing fiber from chitosan, said method comprising:
a) obtaining a polymer solution comprising chitosan and a hydrochloric acid; and
b) extruding the polymer solution into a coagulating bath comprising tris base.
14. The method of claim 13 , wherein the concentration of the hydrochloric acid is about 1%.
15. The method of claim 13 , wherein the concentration of tris base is between about 5% and about 15%.
16. The method of claim 13 , is further comprising adding microspheres comprising at least one biomolecule to the chitosan solution prior to extruding.
17. The method of claim 16 , wherein the biomolecule microsphere is made from a either a pure polymer, or is a copolymer or blend of the polymers selected from the group consisting of poly(L-lactic acid), poly(DL-lactic acid), poly(glycolic acid), polycaprolactone, and polyanhydridepoly(L-lactic acid).
18. The method of claim 13 , further comprising applying at least one polymer coating comprising containing a biomolecule emulsion to said fibers thereby rendering said fibers capable of temporally controlling release of said multiple biomolecules, wherein said applying step is prior to the extruding step.
19. The method of claim 18 , wherein said applying comprises passing said fiber through a spinneret comprising the emulsion.
20. The method of claim 13 , further comprising assembling multiple fibers into a fabric, each wherein one or more fibers of said fabric comprising at least one biomolecule having a specific activity for a certain cell type, wherein said biomolecule may differ from the biomolecule in other fibers in said fabric.
21. The method of claim 20 , wherein the fibers release the biomolecules over a period of time.
22. The method of claim 20 , wherein at least a portion of the fibers may be coated to release various factors and chemicals over a period of time.
23. The method of claim 22 , wherein a first portion of the coated fibers correspond to a first phase of dermal wound healing, a second portion of the coated fibers correspond to a second phase of dermal wound healing and a third portion of the coated fibers correspond to a third phase of dermal wound healing.